Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Yangbing Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2250-8513; OpenAlex author ID A5071716763. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 1 paper

Papers 3

  1. Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study. Co-author DOI 10.1097/js9.0000000000000264↗
  2. Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort. Co-author DOI 10.1016/j.ebiom.2021.103716↗
  3. A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.634881↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenghong Peng · 3 shared papers, 2021–2023 · strength 0.35
  2. Siyi Zou · 3 shared papers, 2021–2023 · strength 0.35
  3. Xiaxing Deng · 3 shared papers, 2021–2023 · strength 0.35
  4. Chenlei Wen · 3 shared papers, 2021–2023 · strength 0.35
  5. Qian Zhan · 2 shared papers, 2021 · strength 0.22
  6. Hao Chen · 2 shared papers, 2021 · strength 0.22
  7. Baiyong Shen · 2 shared papers, 2021 · strength 0.22
  8. Xiongxiong Lu · 2 shared papers, 2021–2023 · strength 0.22
  9. Henghui Zhang · 2 shared papers, 2021–2023 · strength 0.22
  10. Dongfeng Cheng · 2 shared papers, 2021–2023 · strength 0.22
  11. Jiancheng Wang · 2 shared papers, 2021–2023 · strength 0.22
  12. Jiabin Jin · 2 shared papers, 2021–2023 · strength 0.22
  13. Hao Chen · 1 shared paper, 2023 · strength 0.13
  14. Qian Zhan · 1 shared paper, 2023 · strength 0.13
  15. Baiyong Shen · 1 shared paper, 2023 · strength 0.13
  16. Jun Zhang Zhang · 1 shared paper, 2023 · strength 0.13
  17. Jun Zhang · 1 shared paper, 2021 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.